谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

SSRN Electronic Journal(2022)

引用 1|浏览25
暂无评分
关键词
heterologous boost immunisation,immunogenicity,two-dose,sars-cov,open-label,parallel-control
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要